Diwakar Davar

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 43

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

The oncologist

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

University of Pittsburgh Medical Center

University of Pittsburgh (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh Medical Center Jul 01 2013

United States

Fellow :: Division of Hematology-Oncology

University of Pittsburgh Medical Center Jul 01 2012 - Jun 30 2013

United States

Chief Resident :: Division of General Internal Medicine

University of Pittsburgh Medical Center Jul 01 2010 - Jun 30 2012

United States

Resident :: Division of General Internal Medicine

University of Pittsburgh Medical Center Jun 24 2009 - Jul 01 2010

United States

Internship :: Division of General Internal Medicine

Education History

University of Pittsburgh Jan 01 2012

United States

MSC :: Institute of Clinical Research and Education

Publications

Ludimila Cavalcante, Sreenivasa Chandana, Nehal J Lakhani, Amanda Enstrom, Heidi LeBlanc, Joseph Schmalz, Krisztina Lengyel, Frank Schneider, Heather Thomas, Michael J Chisamore, Stanford L Peng, Allison Naumovski, Diwakar Davar
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab. Journal for immunotherapy of cancer 12 (8) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Dylan Fortman, Arivarasan Karunamurthy, Douglas Hartman, Hong Wang, Lindsey Seigh, Ibrahim Abukhiran, Yana G Najjar, Liron Pantanowitz, Hassane M Zarour, John M Kirkwood, Diwakar Davar
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy. The oncologist 29 (7) (2024)
Dylan Fortman, Arivarasan Karunamurthy, Douglas Hartman, Hong Wang, Lindsey Seigh, Ibrahim Abukhiran, Yana G Najjar, Liron Pantanowitz, Hassane M Zarour, John M Kirkwood, Diwakar Davar
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy. The oncologist 29 (7) (2024)
William H Hicks, Lauren C Gattie, Jeffrey I Traylor, Diwakar Davar, Yana G Najjar, Timothy Eric Richardson, Samuel K McBrayer, Kalil G Abdullah
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy. bioRxiv : the preprint server for biology (2024)
Ann W Silk, Diwakar Davar
Tumor-associated Macrophages in Merkel Cell Carcinoma: Old Balances, New Checks. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Chandra C Ghosh, Lauren Cournoyer, Yujia Liu, Alizee Ballarin, Ilan B Layman, Jason LaPorte, Molly Morrissey, Kayla Fraser, Shriya Perati, Bryan F Cox, Evgeny Yakirevich, Diana O Treaba, Timothy D Murtha, Prajna Guha, Steven C Katz, Diwakar Davar
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases. Journal for immunotherapy of cancer 12 (7) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Chandra C Ghosh, Lauren Cournoyer, Yujia Liu, Alizee Ballarin, Ilan B Layman, Jason LaPorte, Molly Morrissey, Kayla Fraser, Shriya Perati, Bryan F Cox, Evgeny Yakirevich, Diana O Treaba, Timothy D Murtha, Prajna Guha, Steven C Katz, Diwakar Davar
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases. Journal for immunotherapy of cancer 12 (7) (2024)
Elham Nasrollahi, Diwakar Davar
Immunomodulatory Effects of RANK/RANKL Blockade in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Dylan Fortman, Arivarasan Karunamurthy, Douglas Hartman, Hong Wang, Lindsey Seigh, Ibrahim Abukhiran, Yana G Najjar, Liron Pantanowitz, Hassane M Zarour, John M Kirkwood, Diwakar Davar
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy. The oncologist 29 (7) (2024)
Ludimila Cavalcante, Sreenivasa Chandana, Nehal J Lakhani, Amanda Enstrom, Heidi LeBlanc, Joseph Schmalz, Krisztina Lengyel, Frank Schneider, Heather Thomas, Michael J Chisamore, Stanford L Peng, Allison Naumovski, Diwakar Davar
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab. Journal for immunotherapy of cancer 12 (8) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Dylan Fortman, Arivarasan Karunamurthy, Douglas Hartman, Hong Wang, Lindsey Seigh, Ibrahim Abukhiran, Yana G Najjar, Liron Pantanowitz, Hassane M Zarour, John M Kirkwood, Diwakar Davar
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy. The oncologist (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Elham Nasrollahi, Diwakar Davar
Immunomodulatory Effects of RANK/RANKL Blockade in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Ludimila Cavalcante, Sreenivasa Chandana, Nehal J Lakhani, Amanda Enstrom, Heidi LeBlanc, Joseph Schmalz, Krisztina Lengyel, Frank Schneider, Heather Thomas, Michael J Chisamore, Stanford L Peng, Allison Naumovski, Diwakar Davar
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab. Journal for immunotherapy of cancer 12 (8) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Dylan Fortman, Arivarasan Karunamurthy, Douglas Hartman, Hong Wang, Lindsey Seigh, Ibrahim Abukhiran, Yana G Najjar, Liron Pantanowitz, Hassane M Zarour, John M Kirkwood, Diwakar Davar
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy. The oncologist 29 (7) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
William H Hicks, Lauren C Gattie, Jeffrey I Traylor, Diwakar Davar, Yana G Najjar, Timothy Eric Richardson, Samuel K McBrayer, Kalil G Abdullah
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy. bioRxiv : the preprint server for biology (2024)
Diwakar Davar, Ludimila Cavalcante, Nehal J Lakhani, Justin C Moser, Michael Millward, Meredith McKean, Mark Voskoboynik, Rachel E Sanborn, Jaspreet S Grewal, Ajita Narayan, Amita Patnaik, Justin F Gainor, Mario Sznol, Amanda Enstrom, Lori Blanchfield, Heidi LeBlanc, Heather Thomas, Michael J Chisamore, Stanford L Peng, Allison Naumovski
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2). Journal for immunotherapy of cancer 12 (8) (2024)
Diwakar Davar, Ludimila Cavalcante, Nehal J Lakhani, Justin C Moser, Michael Millward, Meredith McKean, Mark Voskoboynik, Rachel E Sanborn, Jaspreet S Grewal, Ajita Narayan, Amita Patnaik, Justin F Gainor, Mario Sznol, Amanda Enstrom, Lori Blanchfield, Heidi LeBlanc, Heather Thomas, Michael J Chisamore, Stanford L Peng, Allison Naumovski
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2). Journal for immunotherapy of cancer 12 (8) (2024)
Diwakar Davar, Ludimila Cavalcante, Nehal J Lakhani, Justin C Moser, Michael Millward, Meredith McKean, Mark Voskoboynik, Rachel E Sanborn, Jaspreet S Grewal, Ajita Narayan, Amita Patnaik, Justin F Gainor, Mario Sznol, Amanda Enstrom, Lori Blanchfield, Heidi LeBlanc, Heather Thomas, Michael J Chisamore, Stanford L Peng, Allison Naumovski
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2). Journal for immunotherapy of cancer 12 (8) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Ann W Silk, Diwakar Davar
Tumor-Associated Macrophages in Merkel Cell Carcinoma: Old Balances, New Checks. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Chandra C Ghosh, Lauren Cournoyer, Yujia Liu, Alizee Ballarin, Ilan B Layman, Jason LaPorte, Molly Morrissey, Kayla Fraser, Shriya Perati, Bryan F Cox, Evgeny Yakirevich, Diana O Treaba, Timothy D Murtha, Prajna Guha, Steven C Katz, Diwakar Davar
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases. Journal for immunotherapy of cancer 12 (7) (2024)
Elham Nasrollahi, Diwakar Davar
Immunomodulatory Effects of RANK/RANKL Blockade in Patients with Cancer. Cancer immunology research (2024)
Joseph Sleiman, Rhonda M Brand, Reetesh Pai, Randall E Brand, John Rhee, Marc Schwartz, Diwakar Davar
Mirroring UC care pathways in refractory immune checkpoint inhibitor (ICI)-mediated colitis: distinct features and common pathways. Clinical journal of gastroenterology (2023)
Ryan C Augustin, Sarah Newman, Aofei Li, Marion Joy, Maureen Lyons, Mary P Pham, Peter Lucas, Katelyn Smith, Cindy Sander, Brian Isett, Diwakar Davar, Yana G Najjar, Hassane M Zarour, John M Kirkwood, Jason John Luke, Riyue Bao
Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma. Journal for immunotherapy of cancer 11 (10) (2023)
Jason John Luke, Rebekah Dadey, Ryan Augustin, Sarah Newman, Krishna Singh, Rose Doerfler, Sarah Behr, Patrice Lee, Brian Isett, Christopher Deitrick, Aofei Li, Marion Joy, Carly Reeder, Katelyn Smith, Julie Urban, Lorenzo Sellitto, Mark Jelinek, Susan Christner, Jan Beumer, Liza Villaruz, Aditi Kulkarni, Diwakar Davar, Andrew Poklepovic, Yana Najjar, Dan Zandberg, Adam Soloff, Tullia C Bruno, Lazar Vujanovic, Heath Skinner, Robert Ferris, Riyue Bao
Tumor cell p38 inhibition to overcome immunotherapy resistance. Research square (2023)
Dylan D Fortman, Drew Hurd, Diwakar Davar
The Microbiome in Advanced Melanoma: Where Are We Now? Current oncology reports (2023)
Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, Diwakar Davar, Geoffrey Thomas Gibney, Omid Hamid, Tina J Hieken, Benjamin Izar, Douglas B Johnson, Rajan P Kulkarni, Jason John Luke, Tara C Mitchell, Meghan J Mooradian, Krista M Rubin, April Ks Salama, Keisuke Shirai, Janis M Taube, Hussein A Tawbi, J Keith Tolley, Caressa Valdueza, Sarah A Weiss, Michael K Wong, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0. Journal for immunotherapy of cancer 11 (10) (2023)
Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, Ahmad A Tarhini, Gary I Cohen, Thach-Giao Truong, Helen H Moon, Diwakar Davar, Mark Allen O'Rourke, Joseph J Stephenson, Brendan D Curti, Walter J Urba, Joanna M Brell, Pauline Funchain, Kari L Kendra, Alexandra P Ikeguchi, Anthony Jaslowski, Charles L Bane, Mark A Taylor, Madhuri Bajaj, Robert M Conry, Robert J Ellis, Theodore F Logan, Noel Laudi, Jeffrey A Sosman, David G Crockett, Andrew L Pecora, Ian J Okazaki, Sowjanya Reganti, Sunandana Chandra, Samantha Guild, Helen X Chen, Howard Z Streicher, Jedd D Wolchok, Antoni Ribas, Joanne M Jeter
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Diwakar Davar, Roberta Zappasodi, Hong Wang, Girish S Naik, Takami Sato, Todd Bauer, David L Bajor, Olivier Rixe, Walter Newman, Jingjing Qi, Aliya Holland, Phillip Wong, Lianna Sifferlen, Diane Piper, Cynthia A Sirard, Taha Merghoub, Jedd D Wolchok, Jason John Luke
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Diwakar Davar, Hassane M Zarour
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Diwakar Davar, Amiran K Dzutsev, John A McCulloch, Richard Rosario Rodrigues, Joe-Marc Chauvin, Robert M Morrison, Richelle N Deblasio, Carmine Menna, Quanquan Ding, Ornella Pagliano, Bochra Zidi, Shuowen Zhang, Jonathan H Badger, Marie Vetizou, Alicia M Cole, Miriam R Fernandes, Stephanie M Prescott, Raquel G F Costa, Ascharya K Balaji, Andrey Morgun, Ivan Vujkovic-Cvijin, Hong Wang, Amir A Borhani, Marc B Schwartz, Howard M Dubner, Scarlett J Ernst, Amy Rose, Yana G Najjar, Yasmine Belkaid, Joanne M Jeter, Giorgio Trinchieri, Hassane M Zarour
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science (New York, N.Y.) 371 (6529) (2021)
Yana G Najjar, Dustin McCurry, Huang Lin, Yan Lin, Yan Zang, Diwakar Davar, Arivarasan Karunamurthy, Joseph J Drabick, Rogerio I Neves, Lisa H Butterfield, Marc S Ernstoff, Igor Puzanov, Joseph J Skitzki, Jennifer Bordeaux, IlaSri B Summit, Jehovana O Bender, Ju Young Kim, Beiru Chen, Ghanashyam Sarikonda, Anil Pahuja, Jennifer Tsau, Zeni Alfonso, Christian Laing, James F Pingpank, Matthew P Holtzman, Cindy Sander, Amy Rose, Hassane M Zarour, Joanne M Jeter, Ahmad A Tarhini
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Antoni Ribas, Theresa Medina, Joanne M Jeter, Yousef Zakharia, Rene Gonzalez, Diwakar Davar, Bartosz Chmielowski, Katie M Campbell, Riyue Bao, Heather Kelley, Aaron Morris, David Mauro, James E Wooldridge, Jason J Luke, George J Weiner, Arthur M Krieg, Mohammed M Milhem
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma. Cancer discovery (2021)
Joe-Marc Chauvin, Mignane Ka, Ornella Pagliano, Carmine Menna, Quanquan Ding, Richelle DeBlasio, Cindy Sander, Jiajie Hou, Xian-Yang Li, Soldano Ferrone, Diwakar Davar, Joanne M Jeter, Robert J Johnston, Alan J Korman, Mark J Smyth, Hassane M Zarour
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Lilit Karapetyan, Jason John Luke, Diwakar Davar
Toll-Like Receptor 9 Agonists in Cancer. OncoTargets and therapy 13 (2020)
Christine A Garcia, Alex El-Ali, Tanya J Rath, Lydia C Contis, Vikram Gorantla, Jan Drappatz, Diwakar Davar
Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases. Journal for immunotherapy of cancer 6 (1) (2018)
Diwakar Davar, Fei Ding, Melissa Saul, Cindy Sander, Ahmad A Tarhini, John M Kirkwood, Hussein A Tawbi
High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute. Journal for immunotherapy of cancer 5 (1) (2017)

Diwakar Davar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Diwakar Davar